Mirum Pharmaceuticals received positive analyst rating updates, including buy ratings and raised price targets, from multiple firms including CLSA and Morgan Stanley.
2 reports, 2 independent
Updated Oct 13
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mirum Pharmaceuticals received positive analyst rating updates, including buy ratings and raised price targets, from multiple firms including CLSA and Morgan Stanley.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.CLSA set a target price and Royal Bank of Canada boosted its target price for Mirum Pharmaceuticals.1 source
Mirum Pharmaceuticals received buy ratings and price target raises from various financial institutions.1 source
Keep exploring
The entities involved
-
Mirum Pharmaceuticals
biopharmaceutical company
-
Morgan Stanley
U.S. investment bank